Vonlerizumab (Anti-TNFRSF4 / OX40 / CD134)
Vonlerizumab (Anti-TNFRSF4 / OX40 / CD134) is a monoclonal antibody targeting TNFRSF4. MW : 145.5 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2325 |
| Sku # | A2325-1mg*25 |
| Pricing | 1mg*25, $5070.00 |